Business

Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA

Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA.

articleAvenir Wellness Solutions Inc.May 2, 20194/company/avenir-wellness-solutions-inc/news/meroven-llc-and-cure-pharmaceutical-enter-exclusive-marketing-and-distribution-agreement-for-spee-d-for-the-usa
Meroven LLC and CURE Pharmaceutical Enter Exclusive  Marketing and Distribution Agreement for Spee-D for the USA

About this update from Avenir Wellness Solutions Inc.

[{"type":"text","content":"\nCHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and distribute Spee-D®, a weekly dose oral thin film Vitamin D3 in the USA.\n Under the terms of the agreement, Meroven LLC will be responsible for conducting all regulatory activities to obtain marketing authorizations for Spee-D as well as marketing and distribution. CURE will be responsible for the manufacture of Spee-D and its supply to Meroven at a predetermined transfer price. “This agreement will broaden the reach of our high dose Vitamin D3 CUREfilm™ across the USA,” said Jessica Rousset, Chief Operating Officer of CURE Pharmaceutical. “As we continue to grow our product pipeline, we look forward to continued and expanded opportunities to work with Meroven.” “CURE Pharmaceutical has cultivated an exceptional reputation in terms of their efficiency and purity of its internal formulation and manufacturing processes,” said Mohammed Alaa, Director of Meroven LLC. “We look forward to a long and fruitful relationship with CURE and anticipate its potential expansion.” For more information, please visit Booth No. 852 at the CPhI North America Conference May 1-2, 2019 where both Meroven LLC and CURE Pharmaceutical representatives will be available. About Spee-D® (vitamin D3) oral thin filmSpee-D is an oral thin film that delivers vitamin D3 formulated with CURE’s proprietary CUREfilm™ technology that ensures high potency and stability. Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, added to others, and available as a dietary supplement. It is also produced endogenously when ultraviolet rays from sunlight strike the skin and trigger vitamin D synthesis. Vitamin D promotes calcium absorption and is essential for bone growth. Vitamin D also prevents rickets in children and osteomalacia in adults. Together with calcium, vitamin D also helps protect older adults from osteoporosis. About CURE PharmaceuticalCURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery system...

More updates from Avenir Wellness Solutions Inc.